Imagine a world where healthcare isn't just about treating symptoms, but revolutionizing outcomes for entire populations—yet hidden challenges like overdiagnosis and inequities threaten to derail progress. That's the compelling reality uncovered in the top-read articles from Population Health, Equity, and Outcomes (PHEO) in 2025, a special quarterly issue of The American Journal of Managed Care®. Readers gravitated toward pieces that delve into how payment structures, societal factors, and strategic health system approaches directly impact patient results and overall care quality. But here's where it gets controversial: these insights not only highlight successes but also spark debates on whether we're diagnosing too aggressively or if equity in care is truly achievable. Let's explore the five most popular articles of the year, complete with key findings and their significance for doctors, hospital executives, and insurance providers. We'll break down the complex ideas step by step, so even newcomers to healthcare policy can follow along easily.
Starting from the fifth spot: 'Outcomes for Hospitals Participating in More- and Less-Mature ACOs.' This study, a quasi-experimental analysis, looked at hospitals both before and after they joined the Centers for Medicare & Medicaid Services (CMS) accountable care organizations (ACOs)—which are groups of doctors, hospitals, and other health providers that work together to provide coordinated care—and compared them to similar hospitals that didn't participate. The results? Hospitals in more advanced ACOs saw notable enhancements in certain safety metrics, like fewer unintended injuries from needles or cuts, and early performance differences (seen in less experienced ACOs) tended to close over time. The researchers wrap up by suggesting that joining an ACO, especially as groups gain more experience and take on greater financial risks, can lead to tangible improvements in hospital quality and safety. However, they caution that relying on initial data with limited follow-up might not tell the full story. And this is the part most people miss: could the promise of ACOs be overstated, or are we underestimating their potential to transform hospital care? It's a point worth pondering as healthcare systems evolve.
Climbing to number four: 'Health Impacts of Health System Implementation of a Food-as-Medicine Strategy.' This in-depth case study assessed a healthcare network's program using food as a therapeutic tool, and the findings revealed significant positive changes in nutrition-related results for those involved, including decreased levels of food insecurity and enhancements in certain health markers. The piece breaks down the program's key elements—such as screening for needs, prescribing customized meals or produce, and weaving it into the care team's efforts—and stresses the need for ongoing funding and collaborations across different sectors to broaden its reach. It positions food-as-medicine as a strong approach for improving community health when combined with medical care and a focus on fairness. To make this clearer for beginners, think of it like how a doctor might prescribe exercise or vitamins; here, nutritious food becomes part of the treatment plan, potentially reducing hospital visits for diet-related issues. But here's where it gets controversial—some might argue that food programs divert resources from traditional medicine, sparking questions about priorities in healthcare spending.
Now, at number three: 'Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most.' Drawing from an Institute for Value-Based Medicine® conference, this article summarizes expert discussions on how payment models that reward quality over quantity can accelerate the adoption of cutting-edge heart treatments among underserved groups. Panel members explained how incentives from accountable care setups, bundled payments, or contracts tied to results enable healthcare systems to build stronger teams, better coordinate services, and extend outreach to bridge historical gaps in access. It offers practical policy and operational tips for insurers and health networks to address disparities in cardiology care. For those new to this, value-based care shifts the focus from billing for every visit to rewarding better health outcomes—imagine getting a bonus for keeping patients healthy rather than just treating illnesses. And this is the part most people miss: does tying payments to results truly ensure fairness, or could it inadvertently widen gaps for communities with fewer resources? It's a provocative angle that invites debate on equity in innovation.
Moving to the second place: 'Potential Health Literacy Resources for Health Plans: A Narrative Review.' This comprehensive review outlines practical tools and methods health insurers could use to boost their members' understanding of health information. Covering everything from simple-language guides and materials in multiple languages to interactive digital methods like 'teach-back' sessions and culturally sensitive education, the authors compile evidence that such initiatives can cut down on unnecessary healthcare use, boost compliance with medications, and promote smarter health choices. It also points out obstacles, such as limited internet access or staff shortages, and proposes actionable steps for integrating literacy support into insurance plans and communication efforts. Clarifying for beginners: health literacy is about making complex medical info accessible, like simplifying a doctor's jargon-filled explanation into everyday language to help patients make informed decisions. But here's where it gets controversial—is it the responsibility of insurers to educate, or should patients shoulder more of the burden? This could fuel discussions on where accountability lies in healthcare empowerment.
And finally, claiming the top spot: 'Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage.' In this thought-provoking commentary, the authors argue that the increasing number of adult diagnoses for attention-deficit/hyperactivity disorder (ADHD)—along with evolving prescribing habits—has played a role in the nationwide scarcity of stimulant drugs. They highlight how excessive diagnoses and inconsistent evaluation standards might worsen shortages, hindering access for those who genuinely need the medications. The piece advocates for more rigorous diagnostic practices, standardized guidelines for assessing adult ADHD, and a focus on improving the drug supply chain to guarantee availability for essential treatments. To help beginners grasp this, ADHD is a condition affecting focus and impulse control, often treated with stimulants like those used for attention issues; overdiagnosis means labeling people inaccurately, potentially straining limited resources. And this is the part most people miss: while some view growing awareness as progress, others see it as a crisis of diagnostic accuracy—could subjective judgments be inflating numbers, and at what cost to those with real needs?
These articles from PHEO not only reflect the year's hottest topics but also challenge us to rethink healthcare's future. What do you think—does the push for value-based care genuinely close gaps in access, or is overdiagnosis in conditions like ADHD a bigger threat to equity than we admit? Are food-as-medicine programs a brilliant innovation or a sidetrack from core medical priorities? Share your perspectives and join the conversation in the comments—we'd love to hear your take!
Newsletter
Want to stay on top of evolving policies, costs, and value in healthcare? Sign up for AJMC to get expert analysis where clinical practice meets economic realities.
